XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues        
Revenues from external customers $ 30,424 $ 32,836 $ 60,262 $ 55,421
Operating Expenses        
Impairment of goodwill 9,635 0 9,635 0
Impairment of assets 12,406 0 12,406 0
Other Expense, Net        
Unrealized and realized appreciation in fair value of equity securities and preferred stock, net     (106) 5,702
Equity in net loss of affiliates     (640) (3,387)
Loss from continuing operations before income taxes (43,474) (32,314) (73,376) (85,227)
Loss from discontinued operations, net of income taxes 0 (6,626) (26,056) (15,862)
Net loss (43,354) (38,931) (99,352) (101,067)
Net loss attributable to the noncontrolling interests 0 165 0 1,592
Net loss attributable to Precigen (43,354) (38,766) (99,352) (99,475)
Amounts Attributable to Precigen        
Net loss from continuing operations attributable to Precigen (43,354) (32,140) (73,296) (83,613)
Net loss from discontinued operations attributable to Precigen 0 (6,626) (26,056) (15,862)
Net loss attributable to Precigen $ (43,354) $ (38,766) $ (99,352) $ (99,475)
Net Loss per Share        
Net loss from continuing operations attributable to Precigen per share, basic and diluted (in dollars per share) $ (0.26) $ (0.21) $ (0.45) $ (0.55)
Net loss from discontinued operations attributable to Precigen per share, basic and diluted (in dollars per share) 0 (0.04) (0.16) (0.10)
Net loss attributable to Precigen per share, basic and diluted (in dollars per share) $ (0.26) $ (0.25) $ (0.61) $ (0.65)
Weighted average shares outstanding, basic and diluted (in shares) 164,065,087 153,749,929 162,201,915 153,351,208
Collaborative Arrangement        
Revenues        
Revenues from external customers $ 4,315 $ 6,450 $ 15,036 $ 12,421
Continuing Operations        
Revenues        
Revenues from external customers 30,424 32,836 60,262 55,421
Operating Expenses        
Research and development 14,208 28,239 33,099 55,177
Selling, general and administrative 18,739 19,250 41,757 50,299
Operating expenses 69,899 64,209 125,433 137,010
Operating loss (39,475) (31,373) (65,171) (81,589)
Other Expense, Net        
Unrealized and realized appreciation in fair value of equity securities and preferred stock, net 0 5,760 0 6,209
Interest expense (4,592) (4,353) (9,184) (8,658)
Interest and dividend income 773 1,024 1,446 2,385
Other income (expense), net 71 (2,656) 135 (2,110)
Total other expense, net (3,748) (225) (7,603) (2,174)
Equity in net loss of affiliates (251) (716) (602) (1,464)
Loss from continuing operations before income taxes (43,474) (32,314) (73,376) (85,227)
Income tax benefit 120 9 80 22
Loss from continuing operations (43,354) (32,305) (73,296) (85,205)
Continuing Operations | Collaborative Arrangement        
Revenues        
Revenues from external customers 4,315 6,450 15,036 12,421
Continuing Operations | Products        
Revenues        
Revenues from external customers 8,540 7,800 13,501 12,637
Operating Expenses        
Cost of products and services 8,141 8,502 14,230 16,224
Continuing Operations | Services        
Revenues        
Revenues from external customers 17,381 18,400 31,327 29,783
Operating Expenses        
Cost of products and services 6,770 8,218 14,306 15,310
Continuing Operations | Other        
Revenues        
Revenues from external customers $ 188 $ 186 $ 398 $ 580